⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Antitumor ADC Drugs Market Forecast Shows Strong 12.86% CAGR Through 2035
globenewswire.com
PFE
AZN
DSNKY
GILD
IMMU
REGN
BIIB
BMY
MRK
NVS
AMGN
LLY
JNJ
ABBV
BNTX
SEGN
RHHBY
Takeda
IQV
PE
CD38-Targeted Immunotherapies Pipeline and Competitive Intelligence Report 2025: Darzalex Became the Number 4 Blockbuster Biologic, Just Behind Keytruda, Dupixent and Skyrizi
globenewswire.com
MRK
SNY
REGN
Chemotherapy-induced Peripheral Neuropathy Treatment Market Poised for Strong Growth Throughout the Forecast Period (2025–2034) Amid Rising Chemotherapy Adoption | DelveInsight
globenewswire.com
WEX
ATX
ASMF
VELO
WSNT
LEX
VRTX
PFE
REGN
LLY
GSK
NVO
ISPC
MRK
SCIX
Liver Cancer Drug Market Poised to Reach US$ 17.2 Billion by 2033 Amid Rapid Advances in Targeted Therapies | Astute Analytica
globenewswire.com
BMY
MRK
AZN
ELVN
REGN
GILD
NVS
SNY
Press Release: Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria
globenewswire.com
REGN
SNY
Companies Prioritize Revenue Performance with AI, ISG Says
businesswire.com
III
ANAB
XACT
ORCL
CRM
SAP
WDAY
ACN
IBM
MSFT
GOOG
AMZN
ADBE
NOW
INTU
PAYX
FIS
PAYC
SNOW
DDOG
MDB
PLTR
AI
SMCI
NVDA
AMD
INTC
QCOM
META
NFLX
CMCSA
VZ
T
CSCO
HPQ
DELL
PANW
CRWD
FTNT
ZBRA
CDNS
SNPS
MRVL
NXPI
MU
WDC
AMAT
LRCX
KLAC
ASML
ADI
TXN
ON
MPWR
AEHR
ARM
AVGO
AMGN
GILD
BMY
PFE
MRK
JNJ
LLY
ABBV
MDT
ISRG
BIIB
REGN
AZN
NVS
RHHBY
XOM
CVX
SHEL
TCEHY
BABA
JD
PDD
NTES
BIDU
IQ
VIPS
YY
BEKE
NIO
LI
XPEV
RIVN
LCID
TSLA
GM
F
STLA
TM
HMC
VWAGY
BMW
DAI
GE
HON
BA
LMT
RTX
GD
NOC
CAT
DE
AGCO
CNH
J
CHTR
CMCSK
TMUS
ATVI
EA
TTWO
DIS
FOX
PARA
WBD
LYV
AMC
NCLH
CCL
RCL
DAL
UAL
AAL
LUV
JBLU
ALK
MAR
HLT
IHG
WYNN
LVS
MGM
CHKP
Zscaler
AKR
VAR
NICE
BOARD
FORM
PIG
INFSPM
PERF
FULL
CAP
EVER
JED
OPT
XOXO
ELEV
Dupixent® (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU)
globenewswire.com
REGN
SNY
Peanut Allergy Treatment Market Trends Analysis Report 2025-2033: Product Pipeline Expansion, Rising Disease Burden, Advanced Drug Delivery, and Strategic Player Initiatives Propel Growth - ResearchAndMarkets.com
businesswire.com
AIMT
DBV
SNY
REGN
Zapata Quantum Adds Financial Veteran William Klitgaard to Board as Company Aims to Relist on National Exchange
globenewswire.com
ZPTA
XLNX
SYNH
AVST
CERT
BCRA
LHCG
AMZN
GOOG
MSFT
IBM
ORCL
MRK
DGX
ANTM
UNH
AMGN
GILD
BMY
PFE
ABBV
LRCX
KLAC
ADI
NXPI
QCOM
INTC
AMD
NVDA
MU
SMCI
CRWD
PANW
ZS
SNOW
DDOG
FTNT
TEAM
CRM
NOW
ADBE
INTU
PAYX
ADP
CTAS
WBA
CVS
CI
CNC
ELV
REGN
VRTX
BIIB
ALXN
AZN
NVS
ROG
SNY
XRAY
SYK
BSX
TMO
ILMN
EXAS
MDLZ
KHC
PEP
KO
MCD
SBUX
YUM
CMG
QSR
DNKN
LVS
WYNN
MGM
LULU
NKE
UA
ADDYY
PVH
RL
GPS
TJX
ROST
BBY
HD
LOW
SPG
PLD
AMT
EQIX
CCI
SBAC
PLTR
AI
UPST
SOFI
COIN
PYPL
SQ
AXP
V
MA
JPM
BAC
WFC
GS
MS
SCHW
ETFC
RJF
LPLA
BEN
IVZ
ABR
O
PSA
GOOGL
EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications
globenewswire.com
REGN